These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19822697)
1. The value of serum free light chains in a case of Waldenstrom's macroglobulinaemia that produces a type I cryoglobulinaemia. Pattenden RJ; Davidson KL; Wenham PR Ann Clin Biochem; 2009 Nov; 46(Pt 6):531-2. PubMed ID: 19822697 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report. Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044 [TBL] [Abstract][Full Text] [Related]
4. A case of progression from type II cryoglobulinaemia to Waldenstrom's macroglobulinaemia in a patient with chronic hepatitis C. Neri S; Pulvirenti D; Mauceri B; Ignaccolo L; Azzolina R Clin Exp Med; 2005 May; 5(1):40-2. PubMed ID: 15928881 [TBL] [Abstract][Full Text] [Related]
5. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112 [TBL] [Abstract][Full Text] [Related]
6. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia. Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380 [TBL] [Abstract][Full Text] [Related]
9. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121 [TBL] [Abstract][Full Text] [Related]
10. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119 [TBL] [Abstract][Full Text] [Related]
11. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow. Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia. Kyle RA; Ansell SM; Kapoor P Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118 [TBL] [Abstract][Full Text] [Related]